Catalyst Wire Dossier Catalyst Wire Dossier

Risedronate sodium (generic)

Risedronate sodium · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Risedronate sodium (generic), covering 2023-04-28 to 2023-04-28. Get the full timeline:

Most recent: FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

See pricing